Summary
Latest filing:
Thomas J. Schuetz is CHIEF EXECUTIVE OFFICER, Director of Compass Therapeutics, Inc. (CMPX). 4 SEC Form 4 filings on record going back to 2025, most recently on 10 February 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Thomas J. Schuetz has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Thomas J. Schuetz. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $5.68M of CMPX open-market activity on record
- Carl L. Gordon - $5.68M of CMPX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Thomas J. Schuetz?
Thomas J. Schuetz is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of Compass Therapeutics, Inc. (CMPX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas J. Schuetz last file a Form 4?
The most recent primary Form 4 on record is dated 10 February 2026, one of 4 filings going back to 2025.
Where can I see all of Thomas J. Schuetz's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Thomas J. Schuetz and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
